# Cardiology Medical Scenarios

## Scenario 1: Acute Myocardial Infarction (STEMI)

### Patient Profile
- **Name:** Maria Rodriguez
- **Age:** 62 years
- **Gender:** Female
- **Weight:** 145 lbs (66 kg)
- **Height:** 5'4" (163 cm)
- **BMI:** 24.8

### Medical History
- **Primary:** Type 2 Diabetes Mellitus (10 years)
- **Hypertension** (15 years)
- **Hyperlipidemia** (12 years)
- **Family History:** Father - MI at age 58, Mother - stroke at age 65
- **Social History:** Former smoker (quit 5 years ago, 20 pack-year history)
- **Medications:** Metformin 1000mg BID, Lisinopril 20mg daily, Atorvastatin 40mg daily

### Chief Complaint
"Doctor, I have this terrible chest pain. It's like something is squeezing my chest, and it's going down my left arm. It started about 2 hours ago while I was gardening."

### Vital Signs
- **BP:** 165/95 mmHg
- **HR:** 105 bpm (regular)
- **RR:** 22 breaths/min
- **Temp:** 98.6°F (37°C)
- **SpO2:** 96% on room air
- **Pain Scale:** 8/10

### Physical Examination
- **General:** Appears anxious and in distress
- **Cardiovascular:** Tachycardic, regular rhythm, no murmurs
- **Respiratory:** Clear to auscultation bilaterally
- **Extremities:** No edema, pulses palpable

### Diagnostic Results
- **ECG:** ST elevation in leads II, III, aVF (inferior STEMI)
- **Troponin I:** 2.5 ng/mL (elevated)
- **CBC:** Within normal limits
- **Metabolic Panel:** Glucose 180 mg/dL, Creatinine 1.1 mg/dL
- **Lipid Panel:** Total cholesterol 245 mg/dL, LDL 165 mg/dL

### Clinical Decision Points

#### Immediate Management
1. **MONA Protocol:**
   - Morphine 2-4mg IV for pain control
   - Oxygen 2-4L via nasal cannula
   - Nitroglycerin 0.4mg sublingual
   - Aspirin 325mg PO (if no contraindications)

2. **STEMI Reperfusion Strategy:**
   - Primary PCI preferred (door-to-balloon time <90 minutes)
   - Fibrinolytic therapy if PCI not available within 120 minutes

3. **Dual Antiplatelet Therapy:**
   - Aspirin 162-325mg loading dose
   - P2Y12 inhibitor (Clopidogrel, Prasugrel, or Ticagrelor)

#### Evidence-Based Guidelines
- **ACC/AHA Guidelines 2023:** STEMI management
- **Door-to-balloon time:** <90 minutes for primary PCI
- **PCI preferred** over fibrinolysis when available within 120 minutes

### Treatment Plan
1. **Emergency PCI** - Catheterization lab activation
2. **Medications:** 
   - Atorvastatin 80mg loading dose
   - Beta-blocker (Metoprolol 25mg PO BID)
   - ACE inhibitor (continued Lisinopril)
   - Dual antiplatelet therapy
3. **Post-procedure monitoring** in CCU
4. **Cardiac rehabilitation** referral
5. **Diabetes management** optimization

### Learning Objectives
- Recognize STEMI presentation and ECG changes
- Understand door-to-balloon time importance
- Apply evidence-based reperfusion strategies
- Manage dual antiplatelet therapy
- Coordinate multidisciplinary care

---

## Scenario 2: Heart Failure with Reduced Ejection Fraction

### Patient Profile
- **Name:** Robert Thompson
- **Age:** 68 years
- **Gender:** Male
- **Weight:** 185 lbs (84 kg)
- **Height:** 5'10" (178 cm)
- **BMI:** 26.5

### Medical History
- **Primary:** Ischemic cardiomyopathy
- **Prior MI** (2 years ago)
- **Hypertension** (20 years)
- **Diabetes Mellitus Type 2** (8 years)
- **Medications:** Carvedilol 25mg BID, Lisinopril 10mg daily, Furosemide 40mg daily

### Chief Complaint
"I've been feeling more short of breath lately, especially at night. I have to prop up with three pillows to sleep, and my feet are swollen."

### Vital Signs
- **BP:** 135/85 mmHg
- **HR:** 88 bpm (regular)
- **RR:** 24 breaths/min
- **Temp:** 98.8°F (37.1°C)
- **SpO2:** 92% on room air
- **Weight:** +8 lbs from baseline (4 days)

### Physical Examination
- **General:** Mild respiratory distress when speaking
- **Cardiovascular:** S3 gallop present, no murmurs
- **Respiratory:** Bilateral basilar rales, decreased breath sounds at bases
- **Extremities:** 2+ pitting edema bilaterally to mid-shin

### Diagnostic Results
- **BNP:** 850 pg/mL (elevated)
- **Echo:** LVEF 30%, LV dilation, moderate mitral regurgitation
- **CXR:** Cardiomegaly, pulmonary congestion
- **Labs:** Na 132 mEq/L, Creatinine 1.3 mg/dL

### Clinical Decision Points

#### Heart Failure Classification
- **NYHA Class III** (marked limitation, comfortable at rest)
- **ACC/AHA Stage C** (structural heart disease with prior/current HF symptoms)

#### Evidence-Based Management
1. **Guideline-Directed Medical Therapy (GDMT):**
   - ACE inhibitor/ARB/ARNI
   - Beta-blocker (carvedilol, metoprolol succinate, bisoprolol)
   - Aldosterone antagonist
   - SGLT2 inhibitor

2. **Diuretic Management:**
   - IV loop diuretic for acute decompensation
   - Daily weight monitoring
   - Sodium restriction <2g/day

### Treatment Plan
1. **Acute Management:**
   - IV Furosemide 40mg
   - Oxygen therapy
   - Fluid restriction
   - Daily weights

2. **Optimized GDMT:**
   - Sacubitril/valsartan 49/51mg BID
   - Continue carvedilol 25mg BID
   - Spironolactone 25mg daily
   - Dapagliflozin 10mg daily

3. **Lifestyle Modifications:**
   - Cardiac rehabilitation
   - Sodium restriction
   - Fluid restriction <2L/day
   - Daily weight monitoring

4. **Follow-up:**
   - Weekly weight checks
   - Echo in 3 months
   - HF clinic follow-up in 2 weeks

### Learning Objectives
- Classify heart failure stages and symptoms
- Apply guideline-directed medical therapy
- Monitor for medication side effects
- Recognize decompensation signs
- Implement lifestyle modifications

---

## Scenario 3: Atrial Fibrillation with Rapid Ventricular Response

### Patient Profile
- **Name:** Susan Chen
- **Age:** 55 years
- **Gender:** Female
- **Weight:** 125 lbs (57 kg)
- **Height:** 5'3" (160 cm)
- **BMI:** 22.2

### Medical History
- **Primary:** Paroxysmal atrial fibrillation
- **Hypertension** (10 years)
- **No structural heart disease**
- **Medications:** Amlodipine 5mg daily, occasional acetaminophen

### Chief Complaint
"My heart is racing and fluttering. It started suddenly about an hour ago. I feel lightheaded and short of breath."

### Vital Signs
- **BP:** 110/70 mmHg
- **HR:** 145 bpm (irregularly irregular)
- **RR:** 22 breaths/min
- **Temp:** 98.6°F (37°C)
- **SpO2:** 96% on room air

### Physical Examination
- **General:** Mild distress, alert and oriented
- **Cardiovascular:** Irregularly irregular rhythm, no murmurs
- **Respiratory:** Clear to auscultation
- **Extremities:** No edema, pulses normal

### Diagnostic Results
- **ECG:** Atrial fibrillation with RVR, rate 145 bpm
- **TSH:** Normal (0.8 μIU/mL)
- **Echocardiogram:** Normal LV function, LA enlargement
- **CHADS2-VASc score:** 1 (hypertension)

### Clinical Decision Points

#### Stroke Risk Assessment
- **CHA2DS2-VASc Score:** 1 (1 point for hypertension)
- **HAS-BLED Score:** 1 (no major bleeding risk)
- **Recommendation:** Consider anticoagulation

#### Rate vs. Rhythm Control
- **Rate Control Strategy:** First-line for most patients >65 or with structural heart disease
- **Rhythm Control:** Consider if symptomatic despite rate control

### Treatment Plan
1. **Rate Control:**
   - Metoprolol 25mg PO BID, titrate to HR <110 bpm
   - Diltiazem 120mg daily (alternative if beta-blocker contraindicated)

2. **Anticoagulation:**
   - Apixaban 5mg BID (if CHA2DS2-VASc ≥2 in men, ≥3 in women)
   - Consider for SUSAN since age 55 and female

3. **Electrophysiology Referral:**
   - Cardioversion if persistent symptoms
   - Ablation consultation for recurrent AF

### Learning Objectives
- Recognize atrial fibrillation on ECG
- Calculate stroke risk scores
- Apply rate vs. rhythm control strategies
- Understand anticoagulation indications
- Coordinate cardiology follow-up

---

## Additional Cardiology Scenarios

### Cardiac Arrest (PEA Arrest)
- **Patient:** 45-year-old male, witnessed arrest
- **Initial rhythm:** PEA
- **Focus:** High-quality CPR, epinephrine, identify reversible causes
- **Learning objectives:** ACLS algorithms, post-ROSC care

### Stable Angina
- **Patient:** 58-year-old male with exertional chest pain
- **Focus:** Stress testing, risk stratification
- **Learning objectives:** Chest pain evaluation, CAD assessment

### Hypertensive Emergency
- **Patient:** 42-year-old female with BP 220/120 mmHg
- **Focus:** Acute BP management, target organ damage
- **Learning objectives:** Hypertensive crisis management

---

## References and Guidelines

### Primary Guidelines
1. **ACC/AHA Guidelines for STEMI Management (2023)**
2. **ESC Guidelines for Heart Failure (2021)**
3. **AHA/ACC/HRS Atrial Fibrillation Guidelines (2023)**
4. **ACC/AHA Valvular Heart Disease Guidelines (2020)**

### Key Evidence Sources
- TIMI Risk Score studies
- PARADIGM-HF trial (sacubitril/valsartan)
- ARISTOTLE trial (apixaban)
- CASTLE-AF trial (AF ablation)

### Quality Metrics
- Door-to-balloon time <90 minutes
- HF readmission rates
- AF stroke prevention rates
- Appropriate beta-blocker use post-MI

---

*Note: All scenarios are fictional and created for educational purposes. Patient information has been de-identified and modified for demonstration.*